Zhu et al. found that the lncRNA H19 and its derived miRNA H19-miR-675 were significantly downregulated in advanced prostate cancer and they may be used for diagnostic and therapeutic treatment in advanced prostate cancer because H19-miR-675 could act as a suppressor of prostate cancer metastasis [60]. The gene discussed is H19; the disease is prostate cancer.